A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings ...

The COVID-19 pandemic may be viewed as the single largest disruptor in the history of American healthcare. At Geisinger, the crisis has been a catalyst to accelerate digital transformation. In January ...

PFE faces COVID revenue declines and a patent cliff, but new products, acquisitions and a strong pipeline could fuel growth ...

The US Food and Drug Administration (FDA) on Monday evening issued two guidances intended to accelerate the development of products to treat or prevent coronavirus disease (COVID-19), laying out ...

The US Food and Drug Administration (FDA) on Tuesday detailed a new “special emergency program” for accelerating research and development of potential treatments for coronavirus disease (COVID-19).

The Strategic and Economic Impact of COVID-19 on Associations, a report published last month by Association Laboratory, Inc., points to a shift from traditional membership models to more digital ones.

HARTFORD — The 68 confirmed cases of COVID-19, announced Tuesday, likely translate to at least 6,800 Connecticut residents infected, the state’s top epidemiologist said, as Gov. Ned Lamont pushed ...

Women on CagriSema lost 25% of their body weight in a post hoc trial analysis, while 79.6% of users had digestive side effects. The drug is not approved. Ice Water, Math Quizzes, and Shocks: The 1948 ...